6550--SUPPLY - GENE EXPRESSION KITS This is a Brand name Requirement
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C24225Q0867
- Agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- New York NY 10029, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Network Contracting Office 2 has issued a brand name requirement solicitation for gene expression reagent kits to support suicide prevention research at the Veterans Integrated Service Network 2. The procurement specifically seeks 10x Genomics assays for single-cell genetics sequencing to investigate drug interactions leading to suicidal behavior in Veterans through the Mental Illness Research, Education, and Clinical Center (MIRECC) at James J. Peters VA Medical Center. The contract structure includes a base year with two one-year option periods, and the solicitation is classified under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC 6550 for In Vitro Diagnostic Substances. Questions regarding the solicitation must be submitted by August 25, 2025, with the response deadline set for August 28, 2025, at 10:00 AM EDT. The contracting officer for this procurement is Aleta Jennette, who can be contacted at Aleta.Jennette@va.gov.
This solicitation does not utilize any set-aside designations and no information regarding potential incumbents or current contractors is provided in the documentation. The required quantities per contract period include 5-6 units of GEM-X Flex v2 Human (384 samples), 1 unit of GEM-X Flex Gene Expression Chip Kit, 22-23 units of GEM-X Flex Sample Preparation v2 Kit, and 1 unit of Dual Index Kit. The delivery destination is the Mount Sinai Medical Center Research Department in Manhattan, New York, with the place of performance specified as New York, NY 10029. Deliveries are scheduled to occur within one month after award for each contract period. No specific award values or budget ranges are disclosed in the available solicitation documents.
Notice text
This is a Brand Name requirement.
Files
| File | Type | Posted |
|---|---|---|
| 36C24225Q0867_2.docx | DOCX document | |
| 36C24225Q0867.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6550--supply - gene expression kits | Award Notice | |
| This notice | Solicitation | |
| 6550--supply - gene expression kits | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| 6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ | Veterans Integrated Service Network 5 | No set-aside | |
| Q301--NEW – STX Specialized Molecular Residual Disease Testing | Veterans Integrated Service Network 17 | No set-aside | |
| Q301--Reference Laboratory Testing | Veterans Integrated Service Network 2 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity